Naveed Sattar
Cardiology — University of Glasgow, United Kingdom
Naveed Sattar
LeadR Profile
Cardiology
Subspecialties: Endocrinology - Public Health
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2005 - 2026
Number : 1897
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Cardiovascular Risk in SELECT-Eligible MI Patients With Overweight or Obesity: The Western Denmark Heart Registry. diabetes mellitus, registries, incidence, heart, obesity, therapeutics, overweight, semaglutide | JACC Adv | 2026 | 0 |
| Retatrutide-Associated Improvements in Cardiovascular Risk Biomarkers in Adults With Obesity With or Without Type 2 Diabetes. diabetes mellitus, anti-obesity agents, lipoproteins, c-reactive protein, cardiovascular diseases, biomarkers, cholesterol, obesity, therapeutics, overweight, lipoproteins, ldl, triglycerides, apolipoproteins, diabetes mellitus, type 2 | Diabetes Obes Metab | 2026 | 0 |
| Association of Age at Type 1 Diabetes Onset With Survival, Cardiovascular, and Kidney Outcomes: A Nationwide Cohort Study. diabetes mellitus, mortality, probability, cohort studies, kidney, diagnosis, diabetes mellitus, type 1 | Diabetes Care | 2026 | 0 |
| Epidemiology, temporal trends, and fibrosis risk stratification in metabolic dysfunction-associated steatotic liver disease in UK primary care: a population-based cohort and nested case-control study. liver diseases, epidemiology, incidence, fibrosis, case-control studies, cohort studies, liver, prevalence, diagnosis | Lancet Reg Health Eur | 2026 | 0 |
| Macrotroponin Complexes and Risk of Cardiovascular Events. research design, troponin, cardiovascular system, blood circulation | Circulation Top journal | 2026 | 0 |
Clinical Studies 59
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 28
Ongoing Clinical Trials
5 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Combination of Biologic and Anti obesity Therapies in Psoriatic Arthritis NCT07443956 — glucagon-like peptide 1, skin, arthritis, psoriatic, blood, arthritis, antibodies, monoclonal, obesity, weight loss, therapeutics, overweight, tissues, joints | N/A | Recruiting | 2026 |
| A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT REAL UK) NCT07247084 — diabetes mellitus, incidence, electronic health records, obesity, records, overweight, diabetes mellitus, type 2 | Phase 4 | Recruiting | 2025 |
| Optimizing Weight Loss Can Continuous Glucose Monitoring Play a Role NCT05890209 — research design, maintenance, body weight, obesity, weight loss, continuous glucose monitoring | N/A | Active not recruiting | 2023 |
| Targeted Assessment in High Risk paTients With dIAbetes to ideNtify Undiagnosed Heart Failure NCT05705869 — diabetes mellitus, heart failure, heart, cardiovascular diseases, secondary care, signs and symptoms, symptom assessment, diabetes mellitus, type 1, diabetes mellitus, type 2 | N/A | Active not recruiting | 2022 |
| CISCO 21 Prevent and Treat Long COVID 19 NCT04900961 — exercise, physical therapists, covid-19, therapeutics, post-acute covid-19 syndrome | N/A | Recruiting | 2021 |
LeadR Networks
Main global connection map